Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of Wulan thirteen-ingredient decoction powder in preparation of medicine for protecting renal injury caused by primary hypertension

A technology for essential hypertension and kidney injury, applied in drug combinations, pharmaceutical formulations, plant raw materials, etc.

Pending Publication Date: 2022-02-15
INNER MONGOLIA MEDICAL UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

According to literature reports, the current research on the effective substance basis of Wulan Shisanwei Decoction mainly focuses on the qualitative and quantitative analysis of a certain component, as well as the study of clinical drug effect observation, but the Mongolian medicine compound is taken as a whole, and the drug effect / Taking pharmacodynamics as an indicator, the in-depth research on the material basis and mechanism of action of Mongolian medicine compound Wulan Shisanwei Decoction powder for antihypertensive and target organ protection has not been reported yet.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Wulan thirteen-ingredient decoction powder in preparation of medicine for protecting renal injury caused by primary hypertension
  • Application of Wulan thirteen-ingredient decoction powder in preparation of medicine for protecting renal injury caused by primary hypertension
  • Application of Wulan thirteen-ingredient decoction powder in preparation of medicine for protecting renal injury caused by primary hypertension

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0012] In order to make the objects and advantages of the present invention clearer, the present invention will be further described in detail below in conjunction with the examples. It should be understood that the specific embodiments described here are only used to explain the present invention, not to limit the present invention.

[0013] . Effect of Wulan Shisanwei Decoction Powder on Blood Pressure of Essential Hypertensive Rats

[0014] Losartan Potassium (LST) was used as a positive control drug to evaluate the blood pressure regulation effect of Wulan Shisanwei Decoction on SHR and age / sex-matched Wistar-Kyoto (WKY) rats. The pre-test results show that the antihypertensive effect of low dose (L) Wulan Shisanwei Tang powder is not obvious; given high dose (H) Wulan Shisanwei Tang powder, because the concentration is too high and the liquid is too thick, The rats could not be fed to the stomach normally, so the medium dose of Wulan Shisanwei Tang powder (0.18g / mL) was...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of Wulan thirteen-ingredient decoction powder in preparation of a medicine for protecting renal injury caused by primary hypertension. Results show that the Wulan thirteen-ingredient decoction powder not only can reduce the blood pressure of SHR, but also can reduce the blood urea nitrogen and creatinine level of SHR, alleviate renal injury and renal fibrosis caused by SHR hypertension, and play a role in protecting the kidney. As for in-vitro drug effect evaluation, hypertension injury modeling and drug administration are conducted on the HEK293 cells through Ang II on the basis of early-stage network pharmacology analysis and prediction, then an immunofluorescence experiment is carried out, and the effect of the Wulan thirteen-ingredient decoction powder on AHR protein expression in Ang II induced HEK293 cell hypertension injury is analyzed by utilizing a high-content imaging technology; and results show that AHR expression can be increased in virtue of a medium-dose (0.0415 mg / mL) Wulan thirteen-ingredient decoction powder administration group and a low-dose (0.0104 mg / mL) Wulan thirteen-ingredient decoction powder administration group.

Description

technical field [0001] The invention relates to the field of preparation of medicaments, in particular to the application of Wulan Shisanwei Decoction powder in the preparation of essential hypertension kidney damage protection medicine. Background technique [0002] Mongolian medicine Wulan thirteen flavor soup powder, composed of Tumuxiang, loquat leaves, flavescens, nasturtium, toosendan, comfrey antler, pearl stem, gardenia, myrobalan, acorn kernel, kaempferia, madder, comfrey Composed of thirteen medicinal materials, it has the effect of clearing blood and heat, and can be used for blood heat, headache, red eyes, and hypertension. Among them, gardenia and acorn kernels are used as monarch medicines, which have the effect of clearing blood; Tumuxiang, pearl stems, kaempferia, flavescens, toosendan, and nasturtium are used as minister medicines, which have the effect of promoting the maturity of fever; comfrey, Rubia, loquat leaves, and comfrey are used as adjuvant drugs...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/906A61P9/12A61P13/12
CPCA61K36/28A61K36/73A61K36/489A61K36/71A61K36/58A61K36/30A61K36/744A61K36/185A61K36/49A61K36/906A61K36/74A61P9/12A61P13/12A61K2300/00
Inventor 杜晓鹂朱彦董玉李刚马岚陈建平
Owner INNER MONGOLIA MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products